436 related articles for article (PubMed ID: 8236258)
1. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
Pals DT; DeGraaf GL
J Pharmacol Exp Ther; 1985 Feb; 232(2):407-12. PubMed ID: 3968642
[TBL] [Abstract][Full Text] [Related]
3. Effects of the selective dopaminergic D2 agonist quinelorane on the activity of dopaminergic and noradrenergic neurons projecting to the diencephalon of the rat.
Eaton MJ; Lookingland KJ; Moore KE
J Pharmacol Exp Ther; 1994 Feb; 268(2):645-52. PubMed ID: 7906734
[TBL] [Abstract][Full Text] [Related]
4. Nomifensine and central monoamine neurons: histofluorescence studies.
Smialowska M
Pol J Pharmacol Pharm; 1977; 29(5):509-19. PubMed ID: 145591
[TBL] [Abstract][Full Text] [Related]
5. Effects of p-chloroamphetamine, a serotonin-depleting drug, on the median eminence and pituitary pars intermedia.
Saland LC; Dail WG; Reyes E
J Neurobiol; 1980 Nov; 11(6):577-89. PubMed ID: 6449562
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of anestrus in rats treated with an antihypertensive agent, losulazine hydrochloride.
Mesfin GM; Johnson GA; Higgins MJ; Morris DF
Toxicol Appl Pharmacol; 1987 Jan; 87(1):91-101. PubMed ID: 3099429
[TBL] [Abstract][Full Text] [Related]
7. The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin.
Székács D; Bodnár I; Mravec B; Kvetnansky R; Vizi ES; Nagy GM; Fekete MI
Neurochem Int; 2007 Jan; 50(2):427-34. PubMed ID: 17141375
[TBL] [Abstract][Full Text] [Related]
8. Age-related alteration in catecholamine activity within microdissected brain regions of ovariectomized Fischer 344 rats.
Estes KS; Simpkins JW
J Neurosci Res; 1984; 11(4):405-17. PubMed ID: 6748112
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of brain catecholamine synthesis and release of prolactin and luteinizing hormone in the ovariectomized rat.
Carr LA; Conway PM; Voogt JL
J Pharmacol Exp Ther; 1975 Jan; 192(1):15-21. PubMed ID: 1123720
[TBL] [Abstract][Full Text] [Related]
11. The actions of xylamine on central noradrenergic neurons.
Dudley MW; Butcher LL; Kammerer RC; Cho AK
J Pharmacol Exp Ther; 1981 Jun; 217(3):834-40. PubMed ID: 7230010
[TBL] [Abstract][Full Text] [Related]
12. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
Shaskan EG; Snyder SH
J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
[No Abstract] [Full Text] [Related]
14. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
Miller RT; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of histamine on the activity of hypothalamic dopaminergic neurons in the rat.
Fleckenstein AE; Lookingland KJ; Moore KE
J Pharmacol Exp Ther; 1994 Jan; 268(1):270-6. PubMed ID: 8301567
[TBL] [Abstract][Full Text] [Related]
16. Flavodilol: a new antihypertensive agent that preferentially depletes peripheral biogenic amines.
Blosser JC; McCreedy S; Parker RB; Kinsolving CR; Watkins BE; Wu ES
J Cardiovasc Pharmacol; 1989 Jul; 14(1):142-56. PubMed ID: 2475706
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain.
Ardis TC; Cahir M; Elliott JJ; Bell R; Reynolds GP; Cooper SJ
J Psychopharmacol; 2009 Jan; 23(1):51-5. PubMed ID: 18562433
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.
Koistinen M; Tuomainen P; Hyytiä P; Kiianmaa K
Alcohol Clin Exp Res; 2001 Nov; 25(11):1605-12. PubMed ID: 11707635
[TBL] [Abstract][Full Text] [Related]
20. Indirect biochemical evidence that reserpine methiodide produces selective depletion of peripheral biogenic amines in rats.
Sreemantula S; Boini KM; Koppula S; Kilari EK; Nammi S
Pharmazie; 2005 Apr; 60(4):294-7. PubMed ID: 15881611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
